Tarsus Pharmaceuticals, Inc. TARS Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock shares outstanding?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock shares outstanding of $248.78M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock shares outstanding changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock shares outstanding increased by 55.4% year-over-year, from $160.11M to $248.78M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock shares outstanding?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock shares outstanding has grown at a 35.3% compound annual growth rate (CAGR), from $68.98M to $312.65M.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.